Citation Impact
Citing Papers
Maternal Care, Gene Expression, and the Transmission of Individual Differences in Stress Reactivity Across Generations
2001 Standout
[14] Measurement of cytosolic free Ca2+ with quin2
1989 StandoutNobel
Expansive discovery of chemically diverse structured macrocyclic oligoamides
2024 StandoutScienceNobel
Accurate de novo design of heterochiral protein–protein interactions
2024 StandoutNobel
Release of Ca2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate
1983 StandoutNature
G Protein-coupled Receptor Kinase and β-Arrestin-mediated Desensitization of the Angiotensin II Type 1A Receptor Elucidated by Diacylglycerol Dynamics
2006 StandoutNobel
Behavioral Consequences of Intracerebral Vasopressin and Oxytocin: Focus on Learning and Memory **This paper is dedicated to our friend and scientific teacher Prof. Dr Armin Ermisch (1935–1995).
1996
Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus
1992 Nature
Vasopressin-stimulated phosphoinositide hydrolysis in cultured rat inner medullary collecting duct cells is mediated by the oxytocin receptor.
1991
A role for central vasopressin in pair bonding in monogamous prairie voles
1993 Nature
Molecular cloning and functional characterization of V2 [8‐lysine] vasopressin and oxytocin receptors from a pig kidney cell line
1993
Dendritically Released Peptides Act as Retrograde Modulators of Afferent Excitation in the Supraoptic Nucleus In Vitro
1997
Neurohypophysial Peptides Stimulate the Phosphorylation of Pre-T Cell Focal Adhesion Kinases
1998
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Small-Molecule Inhibition of c-MYC:MAX Leucine Zipper Formation Is Revealed by Ion Mobility Mass Spectrometry
2012 StandoutNobel
Agonist and antagonist specificities of decidual prostaglandin-releasing oxytocin receptors and myometrial uterotonic oxytocin receptors in pregnant rats
1994
Brain Oxytocin Correlates with Maternal Aggression: Link to Anxiety
2005
Electrophysiology of Oxytocin Actions on Central Neuronsa
1992
Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis
1988 Standout
Bradykinin-mediated effects of ACE inhibition
1992
Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
2001 Standout
Neurohypophyseal Hormone Receptors in the Rat Thymus, Spleen, and Lymphocytes
1990
Vasopressin rapidly stimulates protein kinase C in digitonin‐permeabilized swiss 3T3 cells: Involvement of a pertussis toxin‐insensitive guanine nucleotide binding protein
1989
Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid
1993 StandoutNature
Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain. An autoradiographic study
1991
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Why Does Social Exclusion Hurt? The Relationship Between Social and Physical Pain.
2005 Standout
The adolescent brain and age-related behavioral manifestations
2000 Standout
Evidence that apomorphine induces penile erection and yawning by releasing oxytocin in the central nervous system
1989
The aquaporin family of water channels in kidney
1995 StandoutNobel
Oxytocin induces preservation of social recognition in male rats by activating α‐adrenoceptors of the olfactory bulb
2000
Vasopressin-induced motor effects: Localization of a sensitive site in the amygdala
1992
Oxytocin Control of Maternal Behavior Regulation by Sex Steroids and Offspring Stimulia
1997
Kinetics of arginine-vasopressin uptake at the blood-brain barrier
1990
The amygdala: vigilance and emotion
2000 Standout
Kinin B1 receptors: a review
1995
Store-Operated Calcium Channels
2005 Standout
Localization and characterization of binding sites for vasopressin and oxytocin in the brain of the guinea pig
1992
Constraining Cyclic Peptides To Mimic Protein Structure Motifs
2014
Identification of functional oxytocin receptors in lactating rat mammary gland in vitro
1990
Social amnesia in mice lacking the oxytocin gene
2000 Standout
Photoaffinity labelling of the oxytocin receptor in plasma membranes from rat mammary gland
1989
Oxytocin increases trust in humans
2005 StandoutNature
Role of Oxytocin on Prolactin Secretion during Proestrus and in Different Physiological or Pharmacological Paradigms
1988
A gender-specific mechanism for pair bonding: Oxytocin and partner preference formation in monogamous voles.
1995
Localization of oxytocin binding sites in the human brainstem and upper spinal cord: an autoradiographic study
1989
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
1997 Standout
The role of N-terminal glycosylation in the human oxytocin receptor
1997
Identification of a myometrial oxytocin‐receptor protein
1988
Biobehavioral responses to stress in females: Tend-and-befriend, not fight-or-flight.
2000 Standout
Cloning and Functional Characterization of the Amphibian Mesotocin Receptor, a Member of the Oxytocin/Vasopressin Receptor Superfamily
1996
Oxytocin receptor subtypes in the pregnant rat myometrium and decidua: pharmacological differentiations.
1993
Oxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans
2005 Standout
The vasopressin‐induced excitation of hypoglossal and facial motoneurons in young rats is mediated by V1a but not V1b receptors, and is independent of intracellular calcium signalling
2006
Effects of nonapeptide antagonists on oxytocin- and arginine-vasopressin-induced analgesia in mice
1987
Vasopressin receptor antagonists
2006
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Trends in peptide drug discovery
2021
Impact of high-throughput screening in biomedical research
2011 Standout
Interactive effects of neurohypophyseal neuropeptides with receptor antagonists on passive avoidance behavior: mediation by a cerebral neurohypophyseal hormone receptor?
1991
Pharmacological characteristics and anatomical distribution of [3H]oxytocin-binding sites in the wistar rat brain studied by autoradiography
1987
A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9
2000 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Bradykinin-Induced Collapse of Rat Pheochromocytoma (PC12) Cell Growth Cones: A Role for Tyrosine Kinase Activity
1997
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Interactions of the Hormone Oxytocin with Divalent Metal Ions
2008
Quantitation and early kinetics of inositol lipid changes induced by vasopressin in isolated and cultured hepatocytes.
1983
Optical and Structural Properties of Copper−Oxytocin Dications in the Gas Phase
2009
Coupling of exogenous receptors to phospholipase C in Xenopus oocytes through pertussis toxin-sensitive and -insensitive pathways
1989
Endocrine and Paracrine Regulation of Birth at Term and Preterm*
2000 Standout
Inositol trisphosphate, a novel second messenger in cellular signal transduction
1984 StandoutNature
Desensitization and antagonism of vasopressin-induced phosphoinositide metabolism and elevation of cytosolic free calcium concentration in human platelets
1986
Regulation of adrenergic receptor function by phosphorylation. I. Agonist-promoted desensitization and phosphorylation of alpha 1-adrenergic receptors coupled to inositol phospholipid metabolism in DDT1 MF-2 smooth muscle cells.
1987 StandoutNobel
Phospholipase C-δ1 and oxytocin receptor signalling: evidence of its role as an effector
1998
An oxytocin receptor antagonist infused into the supraoptic nucleus attenuates intranuclear and peripheral release of oxytocin during suckling in conscious rats.
1994
Short-Term Synaptic Plasticity
2002 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Atrial natriuretic peptide and oxytocin induce natriuresis by release of cGMP
1999
Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)
2006 Standout
Oxytocin as an antidiuretic hormone. II. Role of V2 vasopressin receptor
1995
Coupling of the expressed alpha 1B-adrenergic receptor to the phospholipase C pathway in Xenopus oocytes. The role of Go.
1993 StandoutNobel
Basic polyamino acids rich in arginine, lysine, or ornithine cause both enhancement of and refractoriness to formation of endothelium-derived nitric oxide in pulmonary artery and vein.
1989 StandoutNobel
Central blockade of vasopressin V1receptors attenuates postexercise hypotension
2001
N-Heterocyclic Carbenes in Late Transition Metal Catalysis
2009 Standout
Relationship between inositol polyphosphate production and the increase of cytosolic free Ca2+ induced by vasopressin in isolated hepatocytes.
1984
Renal Hemodynamic Response to an Angiotensin II Antagonist, Eprosartan, in Healthy Men
1997
Vasopressin and oxytocin reduce plasma prolactin levels of conscious rats in basal and stress conditions. Study of the characteristics of the receptor involved.
1986
Haemodynamic effects of arginine-vasopressin microinjections into the nucleus tractus solitarius: A comparative study of vasopressin, a selective vasopressin receptor agonist and antagonist, and oxytocin
1984
Rapid breakdown of phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate in rat hepatocytes stimulated by vasopressin and other Ca2+-mobilizing hormones
1983
Specific structure–stability relations in metallopeptides
1999
Effects of peptides and non-peptides on isolated arterial smooth muscles: Role of endothelium
1985
Derangements of renal water handling in liver disease
1985
De novo design of covalently constrained mesosize protein scaffolds with unique tertiary structures
2017 StandoutNobel
Rabbit Uterine Oxytocin Receptors andin VitroContractile Response: Abrupt Changes at Term and the Role of Eicosanoids*
1986
Antagonists of Vasopressor and Antidiuretic Responses to Arginine Vasopressin
1982
Stimulation of 1,2-diacylglycerol accumulation in hepatocytes by vasopressin, epinephrine, and angiotensin II.
1985
Vasopressin causes endothelium-dependent relaxations of the canine basilar artery.
1984
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Inositol trisphosphate and diacylglycerol as second messengers
1984 Standout
Ca2+ Oscillations Induced by Hormonal Stimulation of Individual Fura-2-loaded Hepatocytes
1989 StandoutNobel
Hyponatremia: A Prospective Analysis of Its Epidemiology and the Pathogenetic Role of Vasopressin
1985 Standout
Pathophysiology of Sleep Apnea
2010 Standout
Reciprocal regulation of capacitative and non-capacitative Ca2+ entry in A7r5 vascular smooth muscle cells: only the latter operates during receptor activation
2002
The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C
1991 Standout
Exercise and Hypertension
2004 Standout
The Oxytocin Receptor System: Structure, Function, and Regulation
2001 Standout
Appearance and transient expression of oxytocin receptors in fetal, infant, and peripubertal rat brain studied by autoradiography and electrophysiology
1989
Identification and enzymatic deglycosylation of the myometrial oxytocin receptor using a radioiodinated photoreactive antagonist.
1991
The Molecular Biology of Axon Guidance
1996 StandoutScience
Oxytocin in the Medial Amygdala is Essential for Social Recognition in the Mouse
2001 Standout
Recent Advances in the Synthesis of Fluorinated Amino Acids
2011
Stapled β-Hairpins Featuring 4-Mercaptoproline
2021 StandoutNobel
Oxytocin receptor couples to the 80 kDa Gh alpha family protein in human myometrium.
1996
Aquaporins in the Kidney: From Molecules to Medicine
2002 StandoutNobel
Self-programmed nanovesicle to nanofiber transformation of a dipeptide appended bolaamphiphile and its dose dependent cytotoxic behaviour
2014
Fluoro, Alkylsulfanyl, and Alkylsulfonyl Leaving Groups in Suzuki Cross-Coupling Reactions of Purine 2‘-Deoxynucleosides and Nucleosides
2005
Expression of vasopressin receptors in hamster hypothalamus is sexually dimorphic and dependent upon photoperiod.
1991 StandoutNobel
OPC-21268, an Orally Effective, Nonpeptide Vasopressin V1 Receptor Antagonist
1991 Science
Works of Bernard Lammek being referenced
Analogs of arginine vasopressin modified in the N‐terminal part of the molecule with a conformationally constrained cis‐peptide bond motif
2006
Solid-phase synthesis of 16 potent (selective and nonselective) in vivo antagonists of oxytocin
1989
Effects of bradykinin and prostaglandin inhibition on systemic and regional hemodynamics in conscious normotensive rats
1991
Synthesis and some pharmacological properties of potent and selective antagonists of the vasopressor (V1-receptor) response to arginine-vasopressin
1992
Unusual gain in the coordination ability of vasopressin-like peptides towards Cu2+ ions by insertion of the highly hydrophobic side chain
2002
[1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine]arginine-vasopressin and [1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid)]arginine-vasopressin, two highly potent antagonists of the vasopressor response to arginine-vasopressin
1980
The unusual co-ordination ability of vasopressin-like peptides; potentiometric and spectroscopic studies of some copper(II) and nickel(II) complexes
1989
Synthesis and some pharmacological properties of oxytocin and vasopressin analogs with sarcosine or N-methyl-L-alanine in position 7
1983
Highly Potent 1-Aminocyclohexane-1-Carboxylic Acid Substituted V2Agonists of Arginine Vasopressin
2004
Design, Synthesis, and Structure–Activity Relationship Studies of a Potent PACE4 Inhibitor
2013
Synthesis and some pharmacological properties of [4-threonine,7-sarcosine]oxytocin, a peptide with high oxytocic potency, and of [4-threonine,7-N-methylalanine]oxytocin
1983
Design of potent and selective antagonists of the vasopressor responses to arginine-vasopressin
1982
Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin
1985
A novel bradykinin antagonist with improved properties
1991
Synthetic antagonists of in vivo antidiuretic and vasopressor responses to arginine-vasopressin
1981